Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Example of a jv deal

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Apr 04, 2023 12:06pm

217 Views

Post# 35378814

RE:Example of a jv deal

Always appreciate your effort to drum up positive news, though there's an element of conflating unrelated drug successes with TLTs projected success. You would think that all the smart minds and investors would know about the tremendous potential of TLD1433. But we're at 20 cents USD. What does that tell us? We're in the shadows till BTD and maybe till AA. No matter what conference they present at.

<< Previous

Bullboard Posts

Next >>

Global Tungsten Market and Supply Security